Presented by: Kara Fitzgerald, ND, IFMCP
DNA methylation is a well-researched, primary epigenetic process that has been used to establish biological age assessments, namely DNA methylation “clocks,” which act as surrogate markers of age-related morbidity and mortality risk. The potential for reversing biological aging using these clocks is just beginning to be explored. Yet, emerging research suggests that it is possible to do just that. Expansion of healthspan (with lifespan) has profound implications for the growing health-related economic and social challenges of our rapidly aging population. This presentation will explore the ways to reverse biological aging and the latest research in this evolving area.